Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,785 | -12,318 | -8,968 | -6,200 | -3,345 |
| Depreciation Amortization | 258 | 348 | 183 | 120 | 59 |
| Accounts receivable | -2,192 | -177 | -411 | -556 | -543 |
| Accounts payable and accrued liabilities | -15 | 67 | 45 | 77 | 80 |
| Other Working Capital | -1,945 | -955 | -651 | -628 | -861 |
| Other Operating Activity | 2,317 | 2,022 | 1,456 | 1,203 | 801 |
| Operating Cash Flow | $208 | $-11,012 | $-8,345 | $-5,985 | $-3,809 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -120 | -83 | -69 | -37 |
| Investing Cash Flow | $-24 | $-120 | $-83 | $-69 | $-37 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -186 | 7,684 | 5,034 | 3,351 | 1,256 |
| Common Stock Repurchased | -11 | -81 | -72 | -25 | -14 |
| Other Financing Activity | -312 | -333 | -237 | -160 | -38 |
| Financing Cash Flow | $-509 | $7,270 | $4,726 | $3,165 | $1,205 |
| Beginning Cash Position | 1,460 | 5,323 | 5,323 | 5,323 | 5,323 |
| End Cash Position | 1,134 | 1,460 | 1,620 | 2,435 | 2,681 |
| Net Cash Flow | $-326 | $-3,863 | $-3,703 | $-2,888 | $-2,642 |
| Free Cash Flow | |||||
| Operating Cash Flow | 208 | -11,012 | -8,345 | -5,985 | -3,809 |
| Capital Expenditure | -24 | -120 | -83 | -69 | -37 |
| Free Cash Flow | 184 | -11,132 | -8,428 | -6,053 | -3,847 |